KM-001（Kamari Pharma）

N/A

Report date: 2026/03/31 20:00:21
NME

Base Information

Drug NameKM-001（Kamari Pharma）
Drug Alias NameKM-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransient receptor potential cation channel subfamily V member 3 channel antagonists
TargetsTransient receptor potential cation channel subfamily V member 3
Therapy Area/IndicationsPruritusKeratosisNeurodermatitis +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyUnited KingdomMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesKamari Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKamari Pharma Ltd
Inactive CompaniesN/A
Active IndicationsPruritusKeratosisNeurodermatitis +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A